Sprint Bioscience AB
STO:SPRINT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sprint Bioscience AB
STO:SPRINT
|
SE |
|
A
|
Amerisourcebergen Corp
F:ABG
|
US |
|
P
|
Parsons Corp
F:59P
|
US |
|
T
|
Target Corp
LSE:0LD8
|
US |
|
Hong Kong Exchanges and Clearing Ltd
HKEX:388
|
HK |
|
Nikkon Holdings Co Ltd
TSE:9072
|
JP |
|
Broadcom Inc
NASDAQ:AVGO
|
US |
|
E
|
Elis SA
F:7EL
|
FR |
|
S
|
Sun Life Financial Inc
NYSE:SLF
|
CA |
|
Rio Tinto Ltd
OTC:RTNTF
|
AU |
Wall St Price Targets
SPRINT Price Targets Summary
Sprint Bioscience AB
According to Wall Street analysts, the average 1-year price target for SPRINT is 4.9 SEK with a low forecast of 4.85 SEK and a high forecast of 5.04 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPRINT's stock price target?
Price Target
4.9
SEK
According to Wall Street analysts, the average 1-year price target for SPRINT is 4.9 SEK with a low forecast of 4.85 SEK and a high forecast of 5.04 SEK.
What is the Revenue forecast for Sprint Bioscience AB?
Projected CAGR
-19%
Over the last 12 years, the compound annual growth rate for Revenue has been 43%. The projected CAGR for the next 3 years is -19%.
What is the Gross Profit forecast for Sprint Bioscience AB?
Projected CAGR
-24%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 2 years is -24%.
What is the Operating Income forecast for Sprint Bioscience AB?
Projected CAGR
-73%
The compound annual growth rate for Operating Income over the next 3 years is -73%.
What is the Pre-Tax Income forecast for Sprint Bioscience AB?
Projected CAGR
-20%
The compound annual growth rate for Pre-Tax Income over the next 2 years is -20%.
What is the Net Income forecast for Sprint Bioscience AB?
Projected CAGR
-15%
The compound annual growth rate for Net Income over the next 2 years is -15%.
